Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VACCIMIL: Vaccination in Inflammatory Rheumatic Disease
NCT02240888Completed
- Sponsor
- Region Skåne
- Start
- Oct 2011
- Primary completion
- Dec 2017
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Open-label trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection (4 arms), sponsored by Region Skåne. Primary endpoint: Antibody response following vaccination. Started Oct 2011; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02240888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02240888.